Recent

% | $
Quotes you view appear here for quick access.

Bio-Path Holdings, Inc. Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    FREE FALL

    by confucious_222 Apr 17, 2015 2:42 PM

    I am new to this stock and was just told about it tonight. The science sounds extremely promising. Good number of institutional holders. There are 89 mil outstanding shares. Do you see dilution? Strong partnership in MD Anderson also good. What is your opinion of how management is running this company? Not many on the message board here. You are right about low cash burn rate. As they get into later stage trials it seems they will need to raise cash. Have they presented at any major conferences?

    Sentiment: Strong Buy

  • Reply to

    FREE FALL

    by confucious_222 Apr 17, 2015 2:42 PM

    They have published in a peer-reviewed journal. Yahoo does not allow links in the message boards, so just scroll through the press releases to find it. Also, this research is happening at MD Anderson Cancer Center, which is a very credible institution. You can look them up.

    Sentiment: Strong Buy

  • Reply to

    FREE FALL

    by confucious_222 Apr 17, 2015 2:42 PM

    I have been watching this stock. How do you know that any of what they claim to be working on has any real potential? Are there public records with supporting statements from independent experts in this area on what BPTH is claiming to have promising results of? If so, where can I find them? I want to believe the potential but I haven't found any credible non-vested source to backup what's going on here.

  • Reply to

    FREE FALL

    by confucious_222 Apr 17, 2015 2:42 PM

    Thanks, great perspective. I think the current situation is mainly disappointment. The trouble is that it encourages speculators to sell short. Expect attempts to shake out potential sellers, so "someone" can accumulate cheap shares.

  • Reply to

    FREE FALL

    by confucious_222 Apr 17, 2015 2:42 PM

    Looks like this is going to take a lot longer than we originally thought. A lot of individual investors are bailing out because they don't want to wait that long for real data. It was a big disappointment when they announced the so-called phase II study. It is really another round of phase I, because they are still testing safety with efficacy as an ancillary concern. As far as I can tell, all the data thus far, that's available to us, demonstrates that their delivery system and the Grb-2 is perfectly safe. Thus, it is frustrating that they continue to study safety.

    I think, essentially, this stock is falling due to impatience of investors and poor communication from the company. There is no fundamental reason for this decline, as the data is the same now as it was when the stock was trading for twice the current price.

    It appears, however, that institutional ownership and insider ownership is holding steady - both above 20%.

    I hope this combination study is being done for the purpose of courting one or more of the companies that make the Ara-C front line therapy that is part of this study. An announcement of a partnership or licensing deal with one of those companies would bounce this stock right back up and then some.

    Also, it is important to note that they have enough cash to operate for two years on the current burn rate. That means they do not have to rush into any deal. I think they can hold out for the best partner or best offer, and they will need more data to get the kind of deal we are all hoping for.

    I added more recently, and I'm going to sit tight for another year or so. Best of luck!

    Sentiment: Strong Buy

  • Massive Liquidation hits BPTH
    And the reason is...?

  • Reply to

    $2.00 - Time to buy

    by wordlender Feb 24, 2015 1:15 PM

    Some folks just got buried under that last truckload they dropped!

  • Back up the truck. Hold for the long haul.

    Sentiment: Strong Buy

BPTH
1.43-0.01(-0.69%)Apr 24 4:00 PMEDT